Home>Topics>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International VRX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. REFILE-Drugmaker Valeant completes $11 billion purchase of Salix

      Headlines

      Wed, 1 Apr 2015

      April 1 (Reuters) - Canada's Valeant Pharmaceuticals International Inc completed its $10.96 billion purchase of Salix Pharmaceuticals Ltd, the acquisitive company said on Wednesday.

    2. Health Care: 3 Picks in a More Expensive Sector

      Headlines

      Wed, 1 Apr 2015

      strategic areas. We see this trend with the pending acquisition of Allergan by Actavis. This trend is also evident with Valeant 's VRX bid for Salix (which may subsequently get outbid by Endo ENDP). Further, AbbVie 's ABBV bid for Pharmacyclics PCYC also

    3. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

      Headlines

      Mon, 23 Mar 2015

      has led to large increases in shareholder returns. We believe shareholders have benefited from firms like Actavis and Valeant VRX buying companies with weak growth prospects, such as Warner, Forest, and Medicis, and we think acquisitions of other companies

    4. Valeant trumps Endo with $10.96 billion bid for Salix Pharma

      Headlines

      Mon, 16 Mar 2015

      (Reuters) - Valeant Pharmaceuticals International Inc increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, eclipsing Endo International Plc , the only other bidder.

    5. UPDATE 5-Valeant trumps Endo with $10.96 billion bid for Salix Pharma

      Headlines

      Mon, 16 Mar 2015

      March 16 (Reuters) - Valeant Pharmaceuticals International Inc increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, eclipsing Endo International Plc, the only other...

    6. Valeant trumps Endo with $10.96 billion bid for Salix Pharma

      Headlines

      Mon, 16 Mar 2015

      (Reuters) - Valeant Pharmaceuticals International Inc increased its takeover offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, eliminating Endo International Plc , the only other bidder for the maker of gastrointestinal drugs.

    7. UPDATE 4-Valeant trumps Endo with $10.96 billion bid for Salix Pharma

      Headlines

      Mon, 16 Mar 2015

      March 16 (Reuters) - Valeant Pharmaceuticals International Inc increased its takeover offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, eliminating Endo International Plc, the only other bidder for the maker of gastrointestinal drugs.

    8. CANADA STOCKS-TSX ends higher on Valeant, brighter sentiment

      Headlines

      Mon, 16 Mar 2015

      TORONTO, March 16 (Reuters) - Canada's main stock index rose on Monday as most major sectors benefited from bullish global equity market sentiment, while a gain in Valeant Pharmaceuticals International Inc provided further support.

    9. CANADA STOCKS-Valeant helps push TSX higher despite drop in oil shares

      Headlines

      Mon, 16 Mar 2015

      TORONTO, March 16 (Reuters) - Canada's main stock index jumped on Monday as a gain in Valeant Pharmaceuticals International Inc helped overcome a drop in oil and gas shares spurred by lower crude prices.

    10. Endo withdraws offer for Salix

      Headlines

      Mon, 16 Mar 2015

      March 16 (Reuters) - Endo International Plc said it would withdraw its cash-and-stock offer to acquire Salix Pharmaceuticals Ltd after Valeant Pharmaceuticals International Inc increased its bid for the bowel drug maker.

    « Prev12345Next »
    Content Partners